CAS Medical Systems Says FORE-SIGHT Cerebral Oximeter Approved In China

(RTTNews) - CAS Medical Systems, Inc. (CASM), a provider of medical devices for non-invasive patient monitoring, Monday said its FORE-SIGHT Cerebral Oximeter has been approved by the China Food and Drug Administration or CFDA for sale in that country.

FORE-SIGHT is the only cerebral oximeter manufactured outside China to have approval from the CFDA.

"The CFDA approval is the culmination of a three-year testing and approval process and reflects the strength of our technology and recognition of the importance of cerebral oximetry to the Chinese medical community," said Thomas M. Patton, President and Chief Executive Officer of CASMED.

The firm's distribution partner Beijing Gloryway Medical will immediately begin selling FORE-SIGHT to its Chinese customers.

The company's target market is the approximately 800 Level 3A hospitals that are the premier medical institutions in the country.